Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update

PN Patsalos, EP Spencer, DJ Berry - Therapeutic drug monitoring, 2018 - journals.lww.com
Background: Antiepileptic drugs (AEDs) are the mainstay of epilepsy treatment. Since 1989,
18 new AEDs have been licensed for clinical use and there are now 27 licensed AEDs in …

Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis

M Lerch, C Mainetti, B Terziroli Beretta-Piccoli… - Clinical reviews in …, 2018 - Springer
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are considered a
delayed-type hypersensitivity reaction to drugs. They represent true medical emergencies …

Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis

N Hama, R Abe, A Gibson, EJ Phillips - The Journal of Allergy and Clinical …, 2022 - Elsevier
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic
symptoms (DIHS/DRESS) is one example of a severe delayed T-cell–mediated adverse …

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update

JH Karnes, AE Rettie, AA Somogyi… - Clinical …, 2021 - Wiley Online Library
Phenytoin is an antiepileptic drug with a narrow therapeutic index and large interpatient
pharmacokinetic variability, partly due to genetic variation in CYP2C9. Furthermore, the …

Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects

C Johannessen Landmark… - Expert opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction: Antiepileptic drugs (AEDs) are the cornerstone of treatment of
patients with epilepsy, and there are presently 27 licensed AEDs making AEDs among the …

An updated review of the molecular mechanisms in drug hypersensitivity

CB Chen, R Abe, RY Pan, CW Wang… - Journal of …, 2018 - Wiley Online Library
Drug hypersensitivity may manifest ranging from milder skin reactions (eg, maculopapular
exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions …

SJS/TEN 2017: building multidisciplinary networks to drive science and translation

KD White, R Abe, M Ardern-Jones… - The Journal of Allergy …, 2018 - Elsevier
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a life-threatening,
immunologically mediated, and usually drug-induced disease with a high burden to …

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine

C Kloypan, N Koomdee, P Satapornpong, T Tempark… - Pharmaceuticals, 2021 - mdpi.com
Human leukocyte antigen (HLA) encoded by the HLA gene is an important modulator for
immune responses and drug hypersensitivity reactions as well. Genetic polymorphisms of …

[HTML][HTML] Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity

VM Lauschke, Y Zhou, M Ingelman-Sundberg - Pharmacology & …, 2019 - Elsevier
Individuals differ substantially in their response to pharmacological treatment. Personalized
medicine aspires to embrace these inter-individual differences and customize therapy by …

Drug reaction with eosinophilia and systemic symptoms (DRESS): focus on the pathophysiological and diagnostic role of viruses

GA Ramirez, M Ripa, S Burastero, G Benanti… - Microorganisms, 2023 - mdpi.com
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a heterogeneous,
multiorgan and potentially life-threatening drug-hypersensitivity reaction (DHR) that occurs …